Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition.

Walsh, D M; Klyubin, I; Fadeeva, J V; Rowan, M J; Selkoe, D J

Walsh, D M; Klyubin, I; Fadeeva, J V; Rowan, M J; Selkoe, D J.

Affiliation

Walsh DM; Department of Neurology, Harvard Medical School and Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA.

Biochem Soc Trans ; 30(4): 552-7, 2002 Aug.

Article in En | MEDLINE | ID: mdl-12196135

Subject(s)

Alzheimer Disease/therapy; Amyloid beta-Peptides/chemistry; Amyloid beta-Peptides/toxicity; Neurotoxins/chemistry; Peptide Fragments/toxicity; Alzheimer Disease/genetics; Amyloid beta-Peptides/antagonists & inhibitors; Cell Death; Humans; Neurons/drug effects; Neurons/pathology; Neurotoxins/toxicity; Peptide Fragments/antagonists & inhibitors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Amyloid beta-Peptides / Alzheimer Disease / Neurotoxins Type of study: Prognostic_studies Limits: Humans Language: En Journal: Biochem Soc Trans Year: 2002 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links